Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation?

Antioxidants and Redox Signaling

Volumn 14, Issue 10, 2011, Pages 1841-1851

  Stankowski, Jeannette N ^a,b   Gupta, Rishi ^c,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINO 5 (2,3,5 TRICHLOROPHENYL)PYRIMIDINE; AMPA RECEPTOR; BILOBALIDE; CASPASE INHIBITOR; FIBRINOLYTIC AGENT; LAMOTRIGINE; LIDOCAINE; N [4 [4 [(3,4 DIHYDRO 6 HYDROXY 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 2 YL)CARBONYL] 1 PIPERAZINYL]PHENYL] 2 THIOPHENECARBOXIMIDAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE; SIPATRIGINE; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ANTIOXIDANT ACTIVITY; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CELL MEMBRANE; HUMAN; HYPERBARIC OXYGEN; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MEMBRANE DEPOLARIZATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STROKE;

EID: 79954571076     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3292     Document Type: Review

References (66)

1. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, and Marks MP. DEFUSE Investigators. Ann Neurol 60: 508-517, 2006.
2. Baron JC. Perfusion thresholds in human cerebral ischemia: Historical perspective and therapeutic implications. Cerbrovasc Dis 11: 2-08, 2001.
3. Beere H and Green DR. Stress management-heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol 11: 6-10, 2001. (Pubitemid 32056181)
4. Beere H. The stress of dying: The role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117: 2641-2651, 2004. (Pubitemid 38997248)
5. Beere HM. Death versus survival: Functional interaction between apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115: 2633-2639, 2005. (Pubitemid 41434386)
6. Bhatt A, Vora NA, Thomas AJ, Majid A, Kassab M, Hammer MD, Uchino K Wechsler L, Jovin TG, and Gupta R. Lower pretreatment cerebral blood volume affects hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery 63: 874-878, 2008.
7. Bruno V, Battaglia G, Copani A, D'Onofrio A, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, and Nicoletti F. Metabotropic glutmate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 21: 1013-1033, 2001. (Pubitemid 32823739)
8. Chabrier PE, Auguet M, Spinnewyn B, Auvin S, Cornet S, Demerle-Pallardy C, Guilmard-Favre C, Marin JG, Pignol B, Gillard-Roubert V, Roussillot-Charnet C, Schulz J, Viossat I, Bigg D, and Moncada S. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy. Proc Natl Acad Sci USA 96: 10824-10829, 1999. (Pubitemid 29442228)
9. Chaudhry K, Rogers R, Gui M, Lai Q, Goel G, Liebelt B, Ji X, Curry A, Carranza A, Jimenez DF, and Ding Y. Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1=2) activation in exercise-reduced neuronal apoptosis after stroke. Neurosci Lett 474:109-114, 2010.
10. Chavez JC, Hurko O, Barone FC, and Feuerstein GZ. Pharmacologic interventions for stroke: Looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke 40: e558-e563, 2009.
11. Chen Q, Chopp M, Bodzin G, and Chen H. Temperature modulation of cerebral depolarization during focal cerebral ischemia in rats: Correlation with ischemic injury. J Cereb Blood Flow Metab 13: 389-394, 1993. (Pubitemid 23129391)
12. Crumrine RC, Bergstrand K, Cooper AT, Faison WL, and Cooper BR. Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke 28: 2230-2237, 1997. (Pubitemid 27497928)
13. Damman P, Hirsch A, Windhausen F, Tijssen JGP, De Winter RJ, and ICTUS Investigators. 5-year clinical outcomes in the ICTUS (Invasive versus conservative treatment in unstable coronary syndromes) Trial: A randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. JACC 55: 858-864, 2010.
14. Danielson SR and Andersen JK. Oxidative and nitrative protein modifications in Parkinson's disease. Free Radic Biol Med 44: 1787-1794, 2008.
15. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM, and EPITHET Investigators. Effects of alteplase beyond 3 hours after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol 7: 299-309, 2008.
16. Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, Koudstaal PJ, Wessel T, for the LUB-INT-13 Investigators. Lubeluzole in acute ischemic stroke treatment. A doubleblind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 31: 2543-2551, 2000.
17. Doyle KP, Simon RP, and Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 55: 310-318, 2008.
18. Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, Yeh ML, and Connolly ES. Pharmacotherapy of cerebral ischemia. Expert Opin Pharmacother 10: 1895-1906, 2009.
19. Erecinska M and Silver IA. Ions and energy in mammalian brain. Prog Neurobiol 43: 37-71, 1994. (Pubitemid 24221854)
20. Fabricius M, Fuhr S, Buatia R, Boutelle M, Hashemi P, Strong AJ, and Lauritzen M. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain 129: 778-790, 2006. (Pubitemid 43278239)
21. Fink JN, Kumar S, Horkan C, Linfante I, Selim MH, Caplan LR, and Schlaug G. The stroke patient who woke up: Clinical and radiological features, including diffusion and perfusion MRI. Stroke 33: 988-993, 2002. (Pubitemid 34293580)
22. Fujitani T, Adachi N, Miyazaki H, Liu K, Nakamura Y, Kataoka K, and Arai T. Lidocaine protects hippocampal neurons against ischemic damage by preventing increase of extracellular excitatory amino acids: A microdialysis study in Mongolian gerbils. Neurosci Lett 179: 91-93, 1994.
23. Fujiwara N, Murata Y, Arai K, Egi Y, Lu J, Wu O, Singhal AB, and Lo EH. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. BMC Neurosci 10: 79-87, 2009.
24. Gilgun-Sherki Y, Rosenbaum Z, Melamed E, and Offen D. Antioxidant therapy in acute central nervous system injury: Current state. Pharmacol Rev 54: 271-284, 2002. (Pubitemid 34575717)
25. Gorter JA, Petrozzino JJ, Aronica EM, Rosenbaum DM, Opitz T, Bennett MVL, Connor JA, and Zukin RS. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2\+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 17: 6179-6188, 1997. (Pubitemid 27329893)
26. Graham SH, Chen J, Lan J, Leach MJ, and Simon RP. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89 in rat middle cerebral artery occlusion. JPET 269: 854-859, 1994. (Pubitemid 24157361)
27. Gu Y, Shrivastava IH, Amara SG, and Bahar I. Molecular simulations elucidate the substrate translocation pathway in a glutamate transporter. Proc Natl Acad Sci USA 106: 2589-2594, 2009.
28. Guluma KZ, Oh H, Yu SW, Meyer BC, Rapp K, and Lyden PD. Effect of endovascular hypothermia on acute ischemic edema: Morphometric analysis of the ICTuS trial. Neruocrit Care 8: 42-47, 2008. (Pubitemid 351378106)
29. Gupta R, Yonas H, Gebel J, Goldstein S, Horowitz M, Grahovac SZ, Wechsler LR, Hammer MD, Uchino K, and Jovin TG. Reduced pretreatment ipislateral middle cerebral blood flow is predictive of symptomatic hemorrhage postintra-arterial thrombolysis in patients with middle cerebral artery occlusion. Stroke 37: 2526-2530, 2006. (Pubitemid 44454673)
30. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, and ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317-1329, 2008.
31. Iida H, Schmeichel AM, Wang Y, Schmelzer JD, and Low PA. Orchestration of the inflammatory response in ischemiareperfusion injury. J Peripher Nerv Syst 12: 131-138, 2007. (Pubitemid 46906335)
32. Jarvis CR, Anderson TR, and Andrew D. Anoxic depolarization mediates acute damage independent of glutamate in neocortical brain slices. Cereb Cortex 11: 249-259, 2001. (Pubitemid 32199645)
33. Joshi I and Andrew RD. Imaging anoxic depolarization during ischemia-like conditions in the mouse hemi-brain slice. J Neurophysiol 85: 414-424, 2001. (Pubitemid 32062152)
34. Jovin TG, Yonas H, Gebel JM, Kanal E, Chang YF, Gahovac SZ, Goldstein S, and Wechsler LR. The cortical ischemic core and the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion. Stroke 34: 2426-2433, 2003. (Pubitemid 37221955)
35. Kidwell CS, Alger JR, and Saver JL. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 35: 2662-2665, 2003.
36. Krieger DW, DeGeorgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, Katzan IL Mayberg MR, and Furlan AJ. Cooling for acute ischemic brain damage (COOL AID). An open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32: 1847-1854, 2001. (Pubitemid 32772218)
37. Latchaw RE, Yonas H, Hunter GJ, Yuh WT, Ueda T, Sorensen AG, Sunshine JL, Biller J, Wechsler L, Higashida R, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 34: 1084-1104, 2003. (Pubitemid 36402992)
38. Lekiefre D and Meldrum BS. The pyrimidine-derivative, BW 1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study. Neuroscience 56: 93-99, 1993. (Pubitemid 23261807)
39. Li J, Liu W, Ding S, Xu W, Guan Y, Zhang JH, and Sun X. Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res 1210: 223-229, 2008.
40. Liberatore GT, Samson A, Bladin C, Schleuning WD, and Medcalf RL. Vampire bat salivary plasminogen activator (Desmoteplase). A unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 34: 537-543, 2003. (Pubitemid 36206361)
41. Liu B, Liao M, Mielke JG, Ning K, Chen Y, Li L, El-Hayek YH, Gomez E, Zukin RS, Fehlings MG, and Wan Q. Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci 26: 5309-5319, 2006. (Pubitemid 44318383)
42. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, et al. Heart disease and stroke statistics-2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-e181, 2009.
43. Loddick SA, MacKenzie A, and Rothwell NJ. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport 7: 1465-1468, 1996. (Pubitemid 26281123)
44. Lopez-Atalaya JP, Roussel BD, Levrat D, Parcq J, Nicole O, Hommet Y, Benchenane K, Castel H, Leprince J, To Van D, Bureau R, Rault S, Vaudry H, Petersen KU, Santos JS, and Vivien D. Toward safer thrombolytic agents in stroke: Molecular requirements for NMDA receptor-mediated neurotoxicity. J Cereb Blood Flow Metab 28: 1212-1221, 2008. (Pubitemid 351733345)
45. Lu D, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, SzaboC, and Clark RSB. Intramitochondrial poly(ADP-ribosylation) contributes to NAD\+ depletion and cell death induced by oxidative stress. J Biol Chem 278: 18426-18433, 2003. (Pubitemid 36799465)
46. Lysko PG, Webb CL, Yue TL, Gu JL, and Feuerstein G. Neuroprotective effects of tetrodotoxin as a Na\+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 25: 2476-2482, 1994. (Pubitemid 24359322)
47. Martin-Schild S, Hallevi H, Shaltoni H Barreto AD, Gonzales NR, Aronowski J, and Savitz S. Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: A pilot study of caffeinol and mild hypothermia. J Stroke Cerebrovasc Dis 18: 85-96, 2009.
48. Mehta SL, Manhas N, and Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54: 34-66, 2007. (Pubitemid 46498164)
49. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, and Lees KR. Mismatch-based delayed thrombolysis: A meta-analysis. Stroke 41: e25-e33, 2010.
50. Noh KM, Yokota H, Mashiko T, Castillo PE, Zukin RS, and Bennett MVL. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci USA 102: 12230-12235, 2005. (Pubitemid 41291157)
51. Onteniente B, Rasika S, Benchoua A, and Guegan C. Molecular pathways in cerebral ischemia. Cues to novel therapeutic strategies. Mol Neurobiol 27: 33-72, 2003. (Pubitemid 36515160)
52. Pellegrini-Giampietro DE, Zukin RS, Bennet MV, Cho S, and Pulsinelli WA. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci USA 89: 10499-10503, 1992.
53. Rami A, Agarwal R, Botez G, and Winckler J. m-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res 866: 299-312, 2000. (Pubitemid 30313034)
54. Rha JH and Saver JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 38:967-973, 2007. (Pubitemid 46568460)
55. Robinson MB. The family of sodium-dependent glutamate transporters: A focus on the GLT-1=EAAT2 subtype. Neurochem Int 33: 479-491, 1998. (Pubitemid 29116223)
56. Savitz SI and Fisher M. Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials. Ann Neurol 61: 396-402, 2007. (Pubitemid 46878767)
57. Singhal AB. Oxygen therapy in stroke: Past, present and future. Int J Stroke 1: 191-200, 2006. (Pubitemid 44541732)
58. Smith SE and Meldrum BS. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke 26: 117-122, 1995.
59. Tapuria N, Kumar Y, Habib MM, Amara MA, Seifalian AM, and Davidson BR. Remote ischemic preconditioning: A novel protective method from ischemia reperfusion injury. A review. J Surg Res 150: 304-330, 2008.
60. Traystman RJ, Kirsch JR, and Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 71: 1185-1195, 1991.
61. Wang Q, Sun AY, Simonyi A, Kalogeris TJ, Miller DK Sun GY, and Korthius RJ. Ethanol preconditioning protects against ischemia=reperfusion-induced brain damage: Role of NADPH oxidase derived ROS. Free Radic Biol Med 43: 1048-1060, 2007. (Pubitemid 47302653)
62. Wang Y, Dawson VL, and Dawson TM. Poly (ADP-ribose) signals to mitochontrial AIF: A key event in parthanatos. Exp Neurol 218: 193-202, 2009.
63. White BC, Sullivan JM, Degracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Raflos JA, and Krause GS. Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. J Neurol Sci 179: 1-33, 2000.
64. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, and Dawson VL. Apoptosis-inducing factors mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Nat Acad Sci USA 103:18314-18319, 2006. (Pubitemid 44871655)
65. Zhao H, Yenari MA, Cheng D, Sapolsky RM, and Steinberg GK. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 85: 1026-1036, 2003. (Pubitemid 36578634)
66. Zhao X, Strong R, Piriyawa P, Palusinski R, Grotta JC, and Aronowski J. Caffeinol at the receptor level. Anti-ischemic effect of N-methyl-D-Aspartate receptor blockade is potentiated by caffeine. Stroke 41: 363-367, 2010.